Drug Information
| Drug General Information | |||||
|---|---|---|---|---|---|
| Drug ID |
D04VZS
|
||||
| Former ID |
DCL000097
|
||||
| Drug Name |
CTS-21166
|
||||
| Indication | Alzheimer disease [ICD9: 331; ICD10:G30] | Phase 1 | [1] | ||
| Company |
CoMentis
|
||||
| Target and Pathway | |||||
| Target(s) | Beta-secretase | Target Info | Inhibitor | [2] | |
| References | |||||
| REF 1 | ClinicalTrials.gov (NCT00621010) Safety Study of CTS21166 to Treat Alzheimer Disease. U.S. National Institutes of Health. | ||||
| REF 2 | ClinicalTrials.gov (NCT00621010) Safety Study of CTS21166 to Treat Alzheimer Disease. U. S. National Institutes of Health. 2008. | ||||
If You Find Any Error in Data or Bug in Web Service, Please Kindly Report It to Dr. Zhou and Dr. Zhang.